Créer un compteSe connecter

Recherches récentes

Aucune recherche récente

Options de recherche

Disponible uniquement lorsque vous êtes connecté.
mastouille.fr est l'un des nombreux serveurs Mastodon indépendants que vous pouvez utiliser pour participer au fédiverse.
Mastouille est une instance Mastodon durable, ouverte, et hébergée en France.

Administré par :

Statistiques du serveur :

672
comptes actifs

mastouille.fr: À proposAnnuaire des profilsPolitique de confidentialité

Mastodon: À proposTélécharger l’applicationRaccourcis clavierVoir le code sourcev4.3.4

#prescriptiondrugs

1 message1 participant0 message aujourd’hui
Public
Bích-Mây Nguyễn :verified:

"President Donald Trump on Monday signed a sweeping executive order setting a 30-day deadline for drugmakers to electively lower the cost of prescription drugs in the U.S. or face new limits down the road over what the government will pay."

apnews.com/article/trump-presc

AP News · Trump executive order gives drugmakers 30-day deadline to lower drug costsPar Amanda Seitz
#healthcare#PrescriptionDrugs#DrugPrices
Public
Bích-Mây Nguyễn :verified:

"The Trump administration has instructed organizations in other countries to stop disbursing H.I.V. medications purchased with U.S. aid, even if the drugs have already been obtained and are sitting in local clinics.

The directive is part of a broader freeze on foreign aid initiated last week."

nytimes.com/2025/01/27/health/

The New York Times · Trump Administration Halts H.I.V. Drug Distribution in Poor CountriesPar Apoorva Mandavilli
#healthcare#PublicHealth#GlobalHealth
Public
Kim Perales

Many of Trump’s voters will be surprised when they discover that their prescription drug costs have skyrocketed.

“Trump’s Make Drug Prices High Again EO rescinded the BIden-Harris order to lower drug costs - to cap the co-payment for generic medications at $2 for Medicare beneficiaries.”
-S Kennedy

#Medicare #Medicaid #Trump #Health #PrescriptionDrugs #USPol

marketwatch.com/story/trump-ro

Public
Miguel Afonso Caetano

"The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty generic drugs, including significant price markups by PBMs for cancer, HIV, and a variety of other critical drugs.

Staff’s latest report found that the ‘Big 3 PBMs’—Caremark Rx, LLC (CVS), Express Scripts, Inc. (ESI), and OptumRx, Inc. (OptumRx)—marked up numerous specialty generic drugs dispensed at their affiliated pharmacies by thousands of percent, and many others by hundreds of percent. Such significant markups allowed the Big 3 PBMs and their affiliated specialty pharmacies to generate more than $7.3 billion in revenue from dispensing drugs in excess of the drugs’ estimated acquisition costs from 2017-2022. The Big 3 PBMs netted such significant revenues all while patient, employer, and other health care plan sponsor payments for drugs steadily increased annually, according to the staff report.

“The FTC staff’s second interim report finds that the three major pharmacy benefit managers hiked costs for a wide range of lifesaving drugs, including medications to treat heart disease and cancer,” said FTC Chair Lina M. Khan. “The FTC should keep using its tools to investigate practices that may inflate drug costs, squeeze independent pharmacies, and deprive Americans of affordable, accessible healthcare—and should act swiftly to stop any illegal conduct.”"

ftc.gov/news-events/news/press

#USA#FTC#Healthcare
Public
Voting is Your POWER

By #Voting for #Democrats We Save OUR LIVES!

In #Minnesota where #Democrats control all 3 branches of state government, a new law goes into effect that Bans Forever Chemicals known as PFAS

Also, in #minnesota health plans will be required to cap co-pays at $25 per one-month supply of prescription drugs used to treat chronic diseases such as diabetes, asthma, and allergies requiring the use of epinephrine auto-injectors #prescriptiondrugs #healthinsurance
#uspol #uspolitics #health #publichealth #environment #diabetes #athsma

ExplorerFlux en direct
À propos